| scholarly article | Q13442814 |
| P50 | author | Marco Presta | Q56855374 |
| Annamaria Naggi | Q59387864 | ||
| Domenico Ribatti | Q59681775 | ||
| Mirella Belleri | Q114320753 | ||
| Paolo Carminati | Q114780592 | ||
| Claudio Pisano | Q115607704 | ||
| Giangiacomo Torri | Q117260166 | ||
| Benito Casu | Q117275020 | ||
| Sergio Penco | Q117275021 | ||
| Marco Guerrini | Q56432888 | ||
| Marco Rusnati | Q56811108 | ||
| P2093 | author name string | Giuseppe Giannini | |
| Sara Guglieri | |||
| Marta Perez | |||
| Giuseppe Cassinelli | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | angiogenesis inhibitor | Q574834 |
| P304 | page(s) | 838-848 | |
| P577 | publication date | 2004-02-01 | |
| P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
| P1476 | title | Undersulfated and glycol-split heparins endowed with antiangiogenic activity | |
| P478 | volume | 47 |
| Q39021925 | A complementary strategy for enhancement of nanoparticle intracellular uptake |
| Q37565298 | Antitumor efficacy of the heparan sulfate mimic roneparstat (SST0001) against sarcoma models involves multi-target inhibition of receptor tyrosine kinases |
| Q38974572 | Carbohydrate-based amphiphilic nano delivery systems for cancer therapy |
| Q34903811 | Chick embryo chorioallantoic membrane as a useful tool to study angiogenesis |
| Q35662223 | Effect of heparan sulfate and gold nanoparticles on muscle development during embryogenesis |
| Q41900600 | Effect of non-anticoagulant N-desulfated heparin on basic fibroblast growth factor expression, angiogenesis, and metastasis of gastric carcinoma in vitro and in vivo |
| Q51806743 | Effect of taurine and gold nanoparticles on the morphological and molecular characteristics of muscle development during chicken embryogenesis. |
| Q36489766 | Extracellular angiogenic growth factor interactions: an angiogenesis interactome survey |
| Q37623543 | Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo. |
| Q58585910 | Heparan Sulfate Mimetics in Cancer Therapy: The Challenge to Define Structural Determinants and the Relevance of Targets for Optimal Activity |
| Q24336040 | Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity |
| Q89338572 | Heparin impairs angiogenic signaling and compensatory lung growth after left pneumonectomy |
| Q37736668 | Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer |
| Q39915392 | Heparin-paclitaxel conjugates using mixed anhydride as intermediate: synthesis, influence of polymer structure on drug release, anticoagulant activity and in vitro efficiency |
| Q38418286 | Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use. |
| Q33860126 | Increased migration of antigen presenting cells to newly-formed lymphatic vessels in transplanted kidneys by glycol-split heparin |
| Q57563789 | Investigating Glycol-Split-Heparin-Derived Inhibitors of Heparanase: A Study of Synthetic Trisaccharides |
| Q36414904 | Low-molecular-weight heparins and angiogenesis |
| Q28743550 | M402, a novel heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasis |
| Q95271959 | MASP-2 Is a Heparin-Binding Protease; Identification of Blocking Oligosaccharides |
| Q45221614 | Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting |
| Q43197470 | Multimers of the fibroblast growth factor (FGF)-FGF receptor-saccharide complex are formed on long oligomers of heparin. |
| Q39233824 | Non-Anticoagulant Heparins Are Hepcidin Antagonists for the Treatment of Anemia. |
| Q91798207 | Non-Anticoagulant Heparins as Heparanase Inhibitors |
| Q37379726 | Non-anticoagulant heparins and inhibition of cancer |
| Q38855728 | Old and new applications of non-anticoagulant heparin |
| Q37323266 | Polyanionic drugs and viral oncogenesis: a novel approach to control infection, tumor-associated inflammation and angiogenesis. |
| Q34721483 | Preparation and characterization of self-assembled nanoparticles based on low-molecular-weight heparin and stearylamine conjugates for controlled delivery of docetaxel |
| Q38319635 | Profiling glycol-split heparins by high-performance liquid chromatography/mass spectrometry analysis of their heparinase-generated oligosaccharides |
| Q34398151 | Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis |
| Q34557376 | Role of endothelial heparanase in delayed-type hypersensitivity |
| Q99707959 | SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2 |
| Q36101233 | Significance of heparanase in cancer and inflammation |
| Q47662409 | Synthesized Heparan Sulfate Competitors Attenuate Pseudomonas aeruginosa Lung Infection. |
| Q39630195 | Target-Specific Cellular Uptake of Taxol-Loaded Heparin-PEG-Folate Nanoparticles |
| Q38974193 | The Chick Embryo Chorioallantoic Membrane as an In Vivo Assay to Study Antiangiogenesis |
Search more.